XML 99 R16.htm IDEA: XBRL DOCUMENT
v2.4.0.8

FEDERAL INCOME TAXES | 12 Months Ended
--- | ---
Dec. 31, 2013
Income Tax Disclosure [Abstract] |
FEDERAL INCOME TAXES | NOTE 8 – FEDERAL INCOME TAXES The consolidated income tax expense (benefit) is as follows:
|  | 2013 |  |  | 2012 |  |  | 2011 |
Current expense (benefit) |  | $ | 0 |  |  | $ | 0 |  |  | $ | 0 |
Deferred expense (benefit) |  |  | 8,092,000 |  |  |  | 5,636,000 |  |  |  | 0 |
Valuation allowance – change in estimate |  |  | 0 |  |  |  | 0 |  |  |  | (27,361,000 | )
Tax expense (benefit) |  | $ | 8,092,000 |  |  | $ | 5,636,000 |  |  | $ | (27,361,000 | )
2011 reflects the reversal of the valuation allowance, which was established in 2009, related to a change in estimate about our ability to realize our net deferred tax assets in future years based on a change in circumstances. A reconciliation of the differences between the federal income tax expense (benefit) recorded and the amount computed by applying the federal statutory rate to income before income taxes is as follows:
|  | 2013 |  |  | 2012 |  |  | 2011 |
Tax at statutory rate (35%) |  | $ | 8,794,000 |  |  | $ | 6,360,000 |  |  | $ | 3,543,000 |
Increase (decrease) from |  |  |  |  |  |  |  |  |  |  |  |
Tax-exempt interest |  |  | (347,000 | ) |  |  | (486,000 | ) |  |  | (595,000 | )
Bank owned life insurance |  |  | (465,000 | ) |  |  | (535,000 | ) |  |  | (622,000 | )
Change in valuation allowance |  |  | 0 |  |  |  | 0 |  |  |  | (29,640,000 | )
Other |  |  | 110,000 |  |  |  | 297,000 |  |  |  | (47,000 | )
Tax expense (benefit) |  | $ | 8,092,000 |  |  | $ | 5,636,000 |  |  | $ | (27,361,000 | )
Significant components of deferred tax assets and liabilities as of December 31, 2013 and 2012 are as follows:
|  | 2013 |  |  | 2012 |
Deferred income tax assets |  |  |  |  |  |  |  |
Allowance for loan losses |  | $ | 7,987,000 |  |  | $ | 10,037,000 |
Net operating loss carryforward |  |  | 4,050,000 |  |  |  | 8,235,000 |
Unrealized loss on securities |  |  | 2,908,000 |  |  |  | 0 |
Tax credit carryforwards |  |  | 1,397,000 |  |  |  | 1,198,000 |
Nonaccrual loan interest income |  |  | 605,000 |  |  |  | 892,000 |
Deferred compensation |  |  | 567,000 |  |  |  | 506,000 |
Deferred loan fees |  |  | 273,000 |  |  |  | 229,000 |
Fair value write-downs on foreclosed properties |  |  | 241,000 |  |  |  | 2,124,000 |
Fair value of interest rate swap |  |  | 92,000 |  |  |  | 390,000 |
Contributions carryforwards |  |  | 0 |  |  |  | 256,000 |
Other |  |  | 343,000 |  |  |  | 369,000 |
|  |  | 18,463,000 |  |  |  | 24,236,000 |
Deferred income tax liabilities |  |  |  |  |  |  |  |
Depreciation |  |  | 419,000 |  |  |  | 491,000 |
Prepaid expenses |  |  | 192,000 |  |  |  | 339,000 |
Unrealized gain on securities |  |  | 0 |  |  |  | 1,278,000 |
Other |  |  | 98,000 |  |  |  | 113,000 |
|  |  | 709,000 |  |  |  | 2,221,000 |
Total net deferred tax asset |  | $ | 17,754,000 |  |  | $ | 22,015,000 |
At December 31, 2013, we had carryforwards of the following tax attributes: gross federal net operating loss of $11.9 million that expires in years 2030 through 2031; general business tax credits of $0.5 million that expire in the years 2028 through 2033; and $0.9 million of federal alternative minimum tax credits with an indefinite life. $0.3 million of the gross federal net operating loss relates to unrealized excess benefits on stock-based compensation for which a tax benefit will be recorded to shareholders’ equity when utilized. Accounting guidance requires us to assess whether a valuation allowance should be carried against our deferred tax assets based on the consideration of all available evidence using a “more likely than not” standard. In making such judgments, we consider both positive and negative evidence and analyze changes in near-term market conditions as well as other factors which may impact future operating results. Significant weight is given to evidence that can be objectively verified. During 2011, we returned to pre-tax profitability for four consecutive quarters. Additionally, we experienced lower provision expense, continued declines in nonperforming assets and problem asset administration costs, a higher net interest margin, further strengthening of our regulatory capital ratios, and additional reductions in wholesale funding. Our analysis of the positive and negative evidence led us to conclude that, as of December 31, 2011, it was more likely than not that we had returned to sustainable profitability in amounts sufficient to allow for realization of our deferred tax assets in future years. Consequently, in 2011 we reversed the valuation allowance that we had previously determined necessary to carry against our entire net deferred tax asset as of December 31, 2010 and 2009. $27.4 million of our December 31, 2010 valuation allowance was reversed due to this change in judgment and the remaining $2.2 million was reduced due to the tax effects of our 2011 pre-tax income. At December 31, 2013, the positive evidence, including that cited above, continues to outweigh any negative evidence and, therefore, we continue to believe it is more likely than not that we will be able to realize all of our deferred tax assets in future years. We had no unrecognized tax benefits at any time during 2013 or 2012 and do not anticipate any significant increase in unrecognized tax benefits during 2014. Should the accrual of any interest or penalties relative to unrecognized tax benefits be necessary, it is our policy to record such accruals in our income tax accounts; no such accruals existed at any time during 2013 or 2012. Our U.S. federal income tax returns are no longer subject to examination for all years before 2010.

X
- Details
Name: | us-gaap_IncomeTaxDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32718-109319 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Article 4 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319 + Details
Name: | us-gaap_IncomeTaxDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration